These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6732226)

  • 1. Single-dose pharmacokinetics of cefsulodin in patients with cystic fibrosis.
    Reed MD; Stern RC; Yamashita TS; Ackers I; Myers CM; Blumer JL
    Antimicrob Agents Chemother; 1984 May; 25(5):579-81. PubMed ID: 6732226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefsulodin kinetics in healthy subjects after intramuscular and intravenous injection.
    Granneman GR; Sennello LT; Sonders RC; Wynne B; Thomas EW
    Clin Pharmacol Ther; 1982 Jan; 31(1):95-103. PubMed ID: 7053312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefepime in cystic fibrosis patients.
    Huls CE; Prince RA; Seilheimer DK; Bosso JA
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1414-6. PubMed ID: 8363368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefsulodin pharmacokinetics in patients with various degrees of renal function.
    Matzke GR; Keane WF
    Antimicrob Agents Chemother; 1983 Mar; 23(3):369-73. PubMed ID: 6847169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects.
    Arvidsson A; Alván G; Strandvik B
    Acta Paediatr Scand; 1983 Mar; 72(2):293-4. PubMed ID: 6837304
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram].
    Fourtillan JB; Bryskier A; Lefebvre MA; Ingrand I
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):501-5. PubMed ID: 6087247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased renal clearance of cefsulodin due to higher glomerular filtration rate in cystic fibrosis.
    Hedman A; Alván G; Strandvik B; Arvidsson A
    Clin Pharmacokinet; 1990 Feb; 18(2):168-75. PubMed ID: 2180614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefsulodin kinetics in renal impairment.
    Gibson TP; Granneman GR; Kallal JE; Sennello LT
    Clin Pharmacol Ther; 1982 May; 31(5):602-8. PubMed ID: 7075110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies of cefsulodin in the pediatric field].
    Minamitani M; Hachimori K; Suzuki M
    Jpn J Antibiot; 1982 Nov; 35(11):2676-82. PubMed ID: 7169666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-dose pharmacokinetics of aztreonam in children with cystic fibrosis.
    Reed MD; Aronoff SC; Stern RC; Yamashita TS; Myers CM; Friedhoff LT; Blumer JL
    Pediatr Pulmonol; 1986; 2(5):282-6. PubMed ID: 3774385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime disposition in acute and stable cystic fibrosis.
    Leeder JS; Spino M; Isles AF; Tesoro AM; Gold R; MacLeod SM
    Clin Pharmacol Ther; 1984 Sep; 36(3):355-62. PubMed ID: 6432400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cefsulodin sodium therapy in cystic fibrosis patients.
    Cabezudo I; Thompson RL; Selden RF; Guenthner SH; Wenzel RP
    Antimicrob Agents Chemother; 1984 Jan; 25(1):4-6. PubMed ID: 6422844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cephalosporin therapeutics in cystic fibrosis.
    Blumer JL; Stern RC; Yamashita TS; Myers CM; Reed MD
    J Pediatr; 1986 May; 108(5 Pt 2):854-60. PubMed ID: 3517273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic evaluation of cefsulodin in children with and without cystic fibrosis treated for infectious diseases.
    Michalsen H; Bergan T; Solberg R
    Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):685-7. PubMed ID: 3807469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on cefsulodin in the pediatric field].
    Aoyama R; Kakizaki Y; Ohnishi A; Izumi Y; Kuronuma T; Nomura Y
    Jpn J Antibiot; 1982 Nov; 35(11):2629-32. PubMed ID: 7169662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefsulodin pharmacokinetics and otitis media.
    Federspil P; Schätzle W; Tiesler E
    Arch Otorhinolaryngol; 1982; 236(2):123-30. PubMed ID: 7150078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pulmonary Pseudomonas aeruginosa infection in cystic fibrosis with cefsulodin.
    Møller NE; Koch C; Vesterhauge S; Jensen K
    Scand J Infect Dis; 1982; 14(3):207-11. PubMed ID: 6815787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dose proportionality of cefpimizole in normal humans after intramuscular administration.
    Lakings DB; Novak E; Friis JM; Lunan CM; Paxton LM
    Antimicrob Agents Chemother; 1986 Feb; 29(2):271-7. PubMed ID: 3717932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefsulodin concentrations in rabbit eyes after intravenous and subconjunctival administration.
    Mester U; Krasemann C; Werner H
    Ophthalmic Res; 1982; 14(2):129-34. PubMed ID: 7088497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ciprofloxacin in cystic fibrosis.
    Davis RL; Koup JR; Williams-Warren J; Weber A; Heggen L; Stempel D; Smith AL
    Antimicrob Agents Chemother; 1987 Jun; 31(6):915-9. PubMed ID: 3619423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.